Treasure Madeleine McGuire

Treasure Madeleine McGuire

Auto-generated profile, based on publicly available information

Treasure Madeleine McGuire

The University of Queensland Brisbane Queensland Australia

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2014 in Canadian Medical Association Journal
Verified
Journal Article
Open access
PDF file
MGMalcolm Gillies
Malcolm Gillies
ARAnggi Ranakusuma
Anggi Ranakusuma
THTammy Hoffmann
Tammy Hoffmann
STSarah Thorning
Sarah Thorning
TMTreasure McGuire
Treasure McGuire
CMChristopher Del Mar
Christopher Del Mar
Background: When prescribing antibiotics for common indications, clinicians need information about both harms and benefits, information that is currently available only from observational studies. We quantified the common harms of the most frequently prescribed antibiotic, amoxicillin, from randomized placebo-controlled trials. Methods: For this systematic review, we searched MEDLINE, Embase and the Cochrane Central Register of Controlled Trials, without language restriction, for any randomized, participant-blinded, placebo-controlled trials of amoxicillin or amoxicillin–clavulanic acid for any indication, in any setting. Our main outcome was any reported adverse event. Results: Of 730 studies identified, we included 45 trials: 27 involving amoxicillin, 17 involving amoxicillin–clavulanic acid and 1 involving both. The indications for antibiotic therapy were variable. The risk of bias was low, although only 25 trials provided data suitable for assessment of harms, which suggested under-reporting. Diarrhea was attributed to amoxicillin only in the form of amoxicillin–clavulanic acid (Peto odds ratio [OR] 3.30, 95% confidence interval [CI] 2.23–4.87). The OR for candidiasis (3 trials) was significantly higher (OR 7.77, 95% CI 2.23–27.11). Rashes, nausea, itching, vomiting and abnormal results on liver function tests were not significantly increased. The results were not altered by sensitivity analyses, nor did funnel plots suggest publication bias. The number of courses of antibiotics needed to harm was 10 (95% CI 6–17) for diarrhea with amoxicillin–clavulanic acid and 27 (95% CI 24–42) for candidiasis with amoxicillin (with or without clavulanic acid). Interpretation: Diarrhea was caused by use of amoxicillin–clavulanic acid, and candidiasis was caused by both amoxicillin and amoxicillin–clavulanic acid. Harms were poorly reported in most trials, and their true incidence may have been higher than reported. Nevertheless, these rates of common harms associated with amoxicillin therapy may inform decisions by helping clinicians to balance harms against benefits.

1 September 2011 in British Journal of General Practice
Verified
Journal Article
Closed access
KMKayalvili Mugunthan
Kayalvili Mugunthan
TMTreasure McGuire
Treasure McGuire
PGPaul Glasziou
Paul Glasziou
Long-term use of benzodiazepines (BZDs) is common. Not only is such use ineffective, but it also has several risks in addition to dependence, and remains a significant problem among the older population. To systematically review randomised controlled trials that evaluate the effectiveness of minimal interventions to reduce the long-term use of BZDs in primary care. Systematic review and meta-analysis of randomised controlled trials in UK general practices. Cochrane Central, MEDLINE, and Embase (1967-2010) were searched for trials of minimal interventions (such as a single letter or one consultation from a GP) for patients in primary care with long-term (>3 months) BZD use. Pooled risk differences were calculated with 95% confidence intervals. From 646 potentially relevant abstracts, three studies (615 patients) met all the inclusion criteria. The pooled risk ratio showed a significant reduction/cessation in BZD consumption in the minimal intervention groups compared to usual care (risk ratio [RR] = 2.04, 95% confidence interval [CI] = 1.5 to 2.8, [corrected] P<0.001; RR = 2.4, 95% CI = 1.3 to 4.3, P = 0.008) respectively. Two studies also reported a significant proportional reduction in consumption of BZD from baseline to 6 months in intervention groups compared to the control group. The secondary outcome of general health status was measured in two studies; both showed a significant improvement in the intervention group. A brief intervention in the form of either a letter or a single consultation by GPs, for long-term users of BZD, is an effective and efficient strategy to decrease or stop their medication, without causing adverse consequences.

1 January 2018 in Menopause
Verified
Journal Article
Closed access
PDF file
RNRifani B. Natari
Rifani B. Natari
ACAlexandra M. Clavarino
Alexandra M. Clavarino
TMTreasure M. McGuire
Treasure M. McGuire
KDKaeleen D. Dingle
Kaeleen D. Dingle
Samantha HollingworthSamantha Hollingworth
Samantha Hollingworth
Objective: To explore the nature of the bidirectional relationship between vasomotor symptoms (VMS) and depression, and to determine whether hot flashes and night sweats differentially affect the association between VMS and depression through their effect on sleep disruption. Methods: Multiple databases were searched from 1961 until July 31, 2016, and a manual search of reference lists of identified articles was conducted. Sixteen articles that involved 10,008 participants were identified and analyzed. Results: The methods of analyses and measurement of VMS and depression varied across the studies. Two studies explored the bidirectional association, but only one was significant in both directions (odds ratio [OR] depression to VMS 3.06, 95% confidence interval [CI] 1.43-6.58; OR VMS to depression 8.88, 95% CI 2.57-30.68). In both cases, the association between VMS leading to depressive symptoms was stronger than the opposite. Eleven studies examined VMS leading to depression, but only five showed a significant effect (OR 1.57-1.81, P ≤ 0.02). Treating VMS and depressive symptoms as continuous variables (n = 3) diminished the relationship. Three studies showed a significant association of depression leading to VMS (OR 1.62-1.94, P ≤ 0.01). We found little evidence for a specific effect of night sweats on the association between VMS and depressive symptoms. The effect might not be related to sleep disruption. Conclusions: There is a bidirectional association between VMS and depressive symptoms. The menopausal transition appears to increase the risk of recurrent episodes of depression that might not be explained only by VMS. Further investigation is needed to explain the differential effect of night sweats and hot flashes on depression.

24 March 2017 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Closed access
PDF file
SGSusan G. Gray
Susan G. Gray
TMTreasure M. McGuire
Treasure M. McGuire
NCNeale Cohen
Neale Cohen
Peter James LittlePeter James Little
Peter James Little

1 February 2018 in Australian Prescriber
Verified
Journal Article
Open access
PDF file
TMTreasure M McGuire
Treasure M McGuire
Which drugs can be useful in improving the milk supply during lactation when non-drug approaches don't work and what are the potential side effects?

20 February 2006 in Medical Journal of Australia
Verified
Journal Article
Closed access
PDF file
BEBarbara E Eldred
Barbara E Eldred
ADAngela J Dean
Angela J Dean
TMTreasure M McGuire
Treasure M McGuire
ANAllan L Nash
Allan L Nash
Vaccination remains a vital strategy in the prevention of infectious disease. Commercial vaccine formulations contain a range of additives or manufacturing residuals, which may contribute to patient...